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SUMMARY
Dientamoeba fragilis is an intestinal protozoan in humans that is commonly associated with diarrhoea and other
gastrointestinal complaints. Studies conducted to investigate the biology of this parasite are limited by methods for in vitro
cultivation. The objective of this study was to improve a biphasic culture medium, based on the Loeﬄer’s slope, by further
supplementation in order to increase the yield of trophozoites in culture. The current in vitro culture ofD. fragilis is a xenic
culture with a mix of bacteria. Three diﬀerent liquid overlays were evaluated including Earle’s balanced salt solution
(EBSS), PBS and Dulbecco’s modiﬁed PBS (DPBS), for their ability to support the in vitro growth of D. fragilis
trophozoites. Out of these 3 overlays EBSS gave the highest increase in the trophozoite numbers. The eﬀect of
supplementation was analysed by supplementing EBSSwith ascorbic acid, ferric ammonium citrate, L-cysteine, cholesterol
and alpha-lipoic acid and quantiﬁcation of in vitro growth by cell counts. A new liquid overlay is here described based upon
EBSS supplemented with cholesterol and ferric ammonium citrate that, in conjunction with the Loeﬄer’s slope, supports
the growth of D. fragilis trophozoites in vitro. This modiﬁed overlay supported a 2-fold increase in the numbers of
trophozoite in culture from all 4 D. fragilis isolates tested, when compared to a PBS overlay. These advances enable the
harvest of a larger number of trophozoites needed for further studies on this parasite.
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INTRODUCTION
Dientamoeba fragilis is a pathogenic intestinal proto-
zoan parasite that has a cosmopolitan distribution
worldwide (Barratt et al. 2011a,b). It has a prevalence
varying from 0·4% to 17% in patients with diarrhoea
(Sawangjaroen et al. 1993). Dientamoeba fragilis
infection may be symptomatic with both acute and
chronic infections aﬀecting both children and adults
(Stark et al. 2007). The most common symptoms are
abdominal pain and diarrhoea (Stark et al. 2010a,b;
Banik et al. 2011; Barratt et al. 2011a). Treatment of
symptomatic patients with eﬀective drug regimens
includes diphetarsone, tetracycline, metronidazole,
ornidazole, iodoquinol, erythromycin, hydroxychi-
noline, paromomycin, and secnidazole (Stark et al.
2010b). Although Dientamoeba was ﬁrst identiﬁed
nearly 100 years ago, not much information is
available regarding the life cycle, mode of trans-
mission, genomics and proteomics of this organism.
The current in vitro culture medium that supports
D. fragilis growth has hardly changed over the last
100 years. Previous descriptions of in vitro culture for
the xenic cultivation of D. fragilis were reviewed
previously (Barratt et al. 2010). They include liver
infusion medium, inspissated horse serum or egg
slopes with an overlay of egg white or serum Ringer’s
solution supplemented with rice starch. The
TYSGM-9 and modiﬁed BD medium could be
used to culture D. fragilis from stool samples (Stark
et al. 2010a). In addition, another recent report
conﬁrmed that TYSGM-9 broth, Robinson’s, mo-
diﬁed BD and Loeﬄer’s medium were able to
support the xenic growth of D. fragilis long term
and out of these 4 media the Loeﬄer’s slope with a
PBS overlay containing rice starch resulted in the
highest number of trophozoites (Barratt et al. 2010).
The current study was carried out in order to try
and improve this biphasic medium by supplementing
with essential growth nutrients. There is consider-
able evidence that cholesterol, iron and lipid sup-
plementation is beneﬁcial for the growth of many
anaerobic protozoa such as Giardia lamblia and
Trichomonas vaginalis (Gillin et al. 1986; Lehker
and Alderete, 1992). In the study reported here,
growth medium supplements were tested for their
ability to enhance the growth ofD. fragilis in vitro, so
that higher yields of trophozoites can be obtained for
future studies.
MATERIALS AND METHODS
Preparation of Loeﬄer’s slopes
The Loeﬄer’s slopes were prepared as described
previously (Barratt et al. 2010).
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Source of D. fragilis trophozoites
Dientamoeba fragilis trophozoites isolated from a
previous study were used (Barratt et al. 2010).
Trophozoites were quantitated by a single cell
count taken from each ﬂask as follows: the sediment
at the bottom of the culture ﬂasks containing the
trophozoites was thoroughly agitated using a Pasteur
pipette to make an even cell suspension from the
liquid overlay. Raw cell counts were determined from
this even cell suspension using a Neubauer chamber.
Comparison of the eﬀect of diﬀerent liquid overlays
with the Loeﬄer’s slope
Astandardmethodologywasusedinalltheexperiments
described here. All experiments were performed in
triplicate to ensure accuracy of the cell counts. The
initial experimental design is described in detail here.
Four diﬀerent liquid overlays were tested in this
experiment namely EBSS, EBSS supplemented with
20mM HEPES, DPBS and PBS. Earle’s balanced
salt solution (EBSS) was prepared (formulation: 6·8 g
NaCl, 0·4 g KCl, 0·2 g CaCl2, 0·2 g MgSO4.7H2O,
0·14 g NaH2PO4.H2O, 2·2 g NaHCO3 and 1·0 g
glucose, pH 7·8) autoclaved and stored in a 1L
Schott bottle. EBSS with 20mM HEPES (4-
(2-hydroxyethyl)-1-piperazine ethanesulfonic acid)
solution was prepared by adding 4·766 g/L HEPES
into the original EBSS formulation. Dulbecco’s
modiﬁed PBS (DPBS) was prepared (formulation:
200mg/L KCl, 200mg/L KH2PO4, 8000mg/L
NaCl, 2160mg/L Na2HPO4.7H2O) with a pH of
7·4 and osmolarity of 280–286mOsm. PBS (Sigma
Aldrich, Catalogue No.P-4417) was prepared with
a pH of 7·4 according to the manufacturer’s
recommendations.
An equal number of trophozoites was added to
culture ﬂasks, containing Loeﬄer’s slopes overlaid
with liquid medium (either EBSS, EBSS with
20mM HEPES, DPBS and PBS as the negative
control), at a ﬁnal concentration of 1×104 tropho-
zoites/ml. Two mg of rice starch were added to all
liquid media as recommended previously (Barratt
et al. 2010). Each culture ﬂask (n=3 for each overlay
evaluated) was then incubated at 37 °C under anaero-
bic conditions and cell counts were performed on
each ﬂask each day. Since the increase in trophozoite
numbers produced at 42 °C is less than 2-fold greater
than that produced at 37 °C, the ﬂasks were incubated
at 37 °C under anaerobic conditions and cell counts
were performed on each ﬂask each day. The use
of 37 °C removes the need for a dedicated 42 °C
incubator. Growth curves were plotted from the
means of the cell counts.
Eﬀect of cholesterol and lipid supplementation on the
growth of D. fragilis
Three overlay formulations were prepared; EBSS
containing either cholesterol (0·01 mg/ml), a
commercial lipid mix (5 ml/L EBSS) or both
(cholesterol 0·01mg/ml and lipid mix 5ml/L of
EBSS). A cholesterol stock solution was prepared
by dissolving cholesterol powder (10mg) (Sigma
Aldrich, Cat. No.C3045) in 5ml of absolute ethanol,
which was ﬁltered through a 0·2 μm Millipore
ﬁlter before use. The commercial lipid mix (Sigma
Aldrich, Cat No. L0288) contains non-animal
derived fatty acids (arachidonic, palmitic, stearic,
linoleic and myristic).
Eﬀect of ferric ammonium citrate, ascorbic acid,
L-cysteine and alpha-lipoic acid on the growth of
D. fragilis
L-cysteine solution (1·1 g/L) (Sigma Aldrich, Cat.
No.C7352), ascorbic acid solution (0·2 g/L) (Sigma
Aldrich, Cat. No. A4544), ferric ammonium citrate
solution (0·23 g/L) (Sigma Aldrich, Cat. No. F5879)
and alpha-lipoic acid solution (0·206 g/L) (Sigma
Aldrich, Cat. No. T1395) was prepared in EBSS. All
these supplements were ﬁlter sterilized and added to
the culture medium which was further supplemented
with 50mg/L of cholesterol.
Comparison of growth of 4 diﬀerent D. fragilis isolates
in the modiﬁed Earle’s balanced salt solution
supplemented with cholesterol and ferric
ammonium citrate
The ability of the 4 isolates described (Barratt et al.
2010) to grow on Loeﬄer’s slopes with an EBSS
overlay supplemented with 40mg/L of ferric
ammonium citrate and 50mg/L of cholesterol was
evaluated. Loeﬄer’s slopes with a PBS overlay were
used as the negative control and cell counts were
obtained daily.
Statistical analysis
In order to compare the diﬀerences in cell densities in
each experiment, the data obtained from all growth
curve experiments were analysed using a paired
t-test.
RESULTS
Comparison of diﬀerent overlays
Figure 1 shows a comparison of the average growth
of isolate 4 in PBS, EBSS, DPBS and EBSS
supplemented with 20mM HEPES. The highest
cell densities ofD. fragilis trophozoites were obtained
in EBSS (P=0·039) in comparison to other overlays.
EBSS supplemented with 20mM HEPES showed
the second best growth of all 4 media (P=0·019)
(Fig. 1). In contrast, DPBS showed poor growth of
trophozoites compared to PBS (Table 1).
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Eﬀect of cholesterol and lipid supplementation on the
growth of D. fragilis
According to Fig. 2 the highest trophozoite num-
bers were obtained with cholesterol supplementation
(P=0·029) followed by cholesterol and lipid
supplementation together (P=0·031) and lipid sup-
plementation alone itself (P=0·026). Cholesterol was
therefore used in all subsequent experiments.
A cholesterol dose-response curve (Fig. 3) shows
that there is a signiﬁcant increase in the growth of
D. fragilis trophozoites with increasing concen-
trations of cholesterol (Table 1). The highest growth
was at a cholesterol concentration of 50mg/L (which
was the highest concentration tested) compared to the
negative control (P=0·018). Concentrations of
10mg/L (P=0·024) and 5mg/L (P=0·025) also
showed signiﬁcant increase in numbers of D. fragilis
trophozoites compared to the control. Therefore a
concentration of 50mg/L cholesterol was incorpor-
ated into the growth media of D. fragilis.
Eﬀect of ferric ammonium citrate, ascorbic acid,
L-cysteine and alpha-lipoic acid on the growth of
D. fragilis
The highest growth ofD. fragilis was observed in the
EBSS supplemented with ferric ammonium citrate
(T=−2·149) even though this result was not signiﬁ-
cant (P=0·121) (Fig. 4). EBSS supplemented with
ascorbic acid also contained higher numbers of
trophozoites compared to the control (T=−2·164,
P=0·119).
EBSS supplemented with L-cysteine resulted in
very poor growth (T=1·733, P=0·181) and incor-
poration of alpha-lipoic acid made no diﬀerence to
the cell numbers observed (T=1·474, P=0·237).
A ferric ammonium citrate dose-response curve
(Fig. 5) shows that there is an increase in cell densities
with increasing concentrations even though these
results were not signiﬁcant (T=−2·003, P=0·139).
The highest cell density observed was with a ferric
ammonium citrate concentration of 40mg/L; there-
fore this amount was incorporated into the growth
media of D. fragilis.
Comparison of the growth of diﬀerent isolates of
D. fragilis in the new modiﬁed EBSS
There was a signiﬁcant increase in the number of
trophozoites of D. fragilis in isolate 1 (P=0·04),
Table 1. Summary of P and T values obtained
using a paired t-test to compare the average growth
of Dientamoeba fragilis under diﬀerent culture
conditions
Paired variables T value P value
Comparison of diﬀerent buﬀer
overlays
PBS compared to EBSS −2·358 0·078
DPBS compared to EBSS −2·722 0·053
EBSS compared to
EBSS + 20mM HEPES
−1·199 0·297
Eﬀect of cholesterol and lipid






EBSS + cholesterol+ lipids
3·259 0·031




0 mg/L compared to 1mg/L −0·229 0·830
0mg/L compared to 5mg/L −2·762 0·051
0mg/L compared to 10mg/L −2·824 0·048
0mg/L compared to 50mg/L −3·079 0·037
Eﬀect of ascorbic acid, L-cysteine,
alpha-lipoic acid and ferric
ammonium citrate






EBSS compared to EBSS + ferric
ammonium citrate
−2·149 0·121




diﬀerent concentrations of ferric
ammonium citrate
0 g/L compared to 0·1 g/L −2·061 0·131
0 g/L compared to 0·2 g/L −2·18 0·117
0 g/L compared to 0·4 g/L −2·003 0·139
Comparison of EBSS
supplemented with cholesterol
and ferric ammonium citrate to PBS
on the average growth of all 4 D.
fragilis isolates
Isolate 1 3·000 0·04
Isolate 2 2·476 0·069
Isolate 3 2·993 0·040
Isolate 4 3·004 0·040
Fig. 1. Growth curves showing average growth of
Dientamoeba fragilis trophozoites in PBS (----), Earls
balanced solution ( ), Dulbecco’s modiﬁed PBS (===)
and Earls balanced salt solution supplemented with
20mM Hepes (. . . .) under anaerobic conditions at 37 °C.
Initial cell counts on day 0 were 10×104/ml for all culture
ﬂasks. The error bars represent standard error of mean
cell counts.
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isolate 3 (P=0·04) and isolate 4 (P=0·04) cultured
withmodiﬁed EBSS containing cholesterol and ferric
ammonium citrate (Fig. 6A) when compared to PBS
(Fig. 6B) (Table 1). Isolate 2 showed an increase with
higher cell densities in EBSS than in PBS but this
diﬀerence was not signiﬁcant at P=0·05 (P=0·069).
DISCUSSION
Dientamoeba fragilis is a trichomonad parasite that is
commonly associated with gastrointestinal disease in
humans with a signiﬁcant prevalence worldwide
(Barratt et al. 2011b). It is often more prevalent
than Giardia in patients with diarrhoea (Barratt et al.
2011b). However, there is limited knowledge avail-
able about the biology, genomics and proteomics of
this parasite. One of the limiting factors in the
molecular studies of D. fragilis is the production
of high cell numbers by in vitro cultivation.
Improvements in culture would greatly help advance
knowledge in these areas (Barratt et al. 2010).
In the ﬁrst instance the basis of the liquid overlay of
D. fragilis in vitro culture was investigated. All 4
overlays PBS, EBSS, DPBS and EBSS sup-
plemented with 20mMHEPES were able to support
growth of D. fragilis. Earle’s Balanced Salt Solution
gave the highest trophozoite numbers and so was
chosen for use in further studies including sup-
plementation with cholesterol and ferric ammonium
citrate. EBSS contains a variety of inorganic salts, as
well as sodium hydrogen carbonate (NaHCO3) and
glucose (Bryant, 1975). The inorganic salts in the
medium help to maintain the osmolarity as well as
providing a range of divalent cations needed for cell
metabolism. NaHCO3 maintains the buﬀering
capacity in the anaerobic in vitro culture and glucose
provides an additional energy source in addition to
the rice starch.
Since the current in vitro culture of D. fragilis
involves a xenic culture which consists of a mix
of bacteria, one could argue that the growth
enhancement observed in these experiments could
be due to an indirect eﬀect through the media
enhancing the growth of favourable bacteria; a direct
eﬀect on D. fragilis or both of these. The reason for
Fig. 3. Growth curves showing average growth of
Dientamoeba fragilis trophozoites in EBSS supplemented
with diﬀerent concentrations of cholesterol under
anaerobic conditions at 37 °C. The cholesterol
concentrations are as follows: 0 mg/L (===), 1 mg/L
( ), 5 mg/L (----), 10 mg/L (. . . .) and 50mg/L
( ). Initial cell counts on day 0 were 3× 104/ml for all
culture ﬂasks. The error bars represent standard error of
mean cell counts.
Fig. 2. Growth curves showing average growth of
Dientamoeba fragilis trophozoites in cholesterol (. . . .),
cholesterol+ lipid ( ), lipid supplemented EBSS
(----) and EBSS which is the negative control (===)
under anaerobic conditions at 37 °C. Initial cell counts on
day 0 were 3× 104/ml for all culture ﬂasks. The error bars
represent standard error of mean cell counts.
Fig. 4. Growth curves showing average growth of
Dientamoeba fragilis trophozoites in EBSS supplemented
with ferric ammonium citrate ( ), ascorbic acid (. . . .),
L-cysteine ( ), alpha lipoic acid (----) and EBSS as
the negative control (===) under anaerobic conditions at
37 °C. Initial cell counts on day 0 were 3× 104/ml for all
culture ﬂasks. The error bars represent standard error of
mean cell counts.
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the increase in trophozoite numbers is still unknown;
whatever the mechanism, the medium formulation
was beneﬁcial in supporting the growth of higher
trophozoite numbers.
Even though no information is available on the
uptake or need for cholesterol in D. fragilis, there is
considerable evidence that highlights the importance
of cholesterol in other anaerobic protozoa (Farthing
et al. 1985; Gillin et al. 1986; Lujan et al. 1996). In
the experiments reported here, supplementation of
culture medium with cholesterol and lipids sup-
ported the growth of D. fragilis signiﬁcantly
and cholesterol supplementation alone resulted in
the highest growth compared to the control.
Consequently cholesterol was used in the culture
medium to enhance the growth of D. fragilis.
There is considerable evidence to highlight the
beneﬁcial eﬀect of the supplements evaluated in this
study. Iron is an important element in the electron
transport pathway which increases the activity of
hydrogenosomal enzymes which are critical to the
energy needs of anaerobic protozoa such as
Trichomonas vaginalis (Lehker and Alderete, 1992;
Amin et al. 2010). Still further studies need to be
carried out in order to recognize the mode of
acquisition of these nutrients by D. fragilis.
Out of all 4 supplements tested, ferric ammonium
citrate and ascorbic acid supported the growth of
D. fragilis, although the numbers were not statisti-
cally signiﬁcant. Incorporation of ferric ammonium
citrate into the medium gave higher numbers of cells
than any of the other supplements. Furthermore the
presence of a partial dose-response type relationship
with increasing concentrations of ferric ammonium
citrate suggests that ferric ammonium citrate aids the
growth of D. fragilis.
The modiﬁed EBSS supplemented with
ferric ammonium citrate and cholesterol was able
to support growth of all the 4 isolates of D. fragilis
tested. The modiﬁed EBSS increased the tro-
phozoite numbers in all 4 isolates more than 2-fold.
Out of the 4 isolates 3 of them showed a signiﬁ-
cant increase in growth with higher cell densities
when compared to PBS which is the liquid
overlay used currently (Barratt et al. 2010). Even
isolate 2, which did not show a signiﬁcant increase
with EBSS, gave higher cell densities in EBSS than
in PBS.
In this study, new advances are described on the in
vitro culture ofD. fragilis. A modiﬁed EBSS contain-
ing cholesterol, ferric ammonium citrate and rice
starch can be regarded as a superior liquid overlay
that can be used along with the Loeﬄer’s serum slope
Fig. 5. Growth curves showing average growth of
Dientamoeba fragilis trophozoites in EBSS supplemented
with diﬀerent concentrations of ferric ammonium citrate
under anaerobic conditions at 37 °C. The ferric
ammonium citrate concentrations were as follows: 0 g/L
(===), 0·1 g/L (----), 0·2 g/L (. . . .), 0·4 g/L ( ).
Initial cell counts on day 0 were 3× 104/ml for all culture




Fig. 6. Growth curves showing average growth of
Dientamoeba fragilis trophozoites of isolate 1 ( ),
isolate 2 (. . . .), isolate 3 (----) and isolate 4 (===) under
anaerobic conditions at 37 °C in (A) modiﬁed EBSS
supplemented with ferric ammonium citrate and
cholesterol or (B) PBS. The error bars represent standard
error of mean cell counts.
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for culture of D. fragilis under anaerobic conditions.
Although these xenic cultures are a vast improvement
over previous technology used for culture, the
presence of bacteria still represents a limitation.
The use of our improved culture method, along
with antibiotic treatment of the cultures, will hope-
fully provide the means for generating monoxenic or
axenic cultures of D. fragilis.
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